4.5 Article

Sex differences in the activity of signalling pathways and expression of G-protein-coupled receptor kinases in the neonatal ventral hippocampal lesion model of schizophrenia

Related references

Note: Only part of the references are listed.
Review Behavioral Sciences

The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia

Kuei Y. Tseng et al.

BEHAVIOURAL BRAIN RESEARCH (2009)

Article Clinical Neurology

Selective reorganization of GABAergic transmission in neonatal ventral hippocampal-lesioned rats

Jennifer Francois et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2009)

Article Neurosciences

Lateralized sex differences in stress-induced dopamine release in the rat

Ron M. Sullivan et al.

NEUROREPORT (2009)

Article Clinical Neurology

Enhanced α1 adrenergic sensitivity in sensorimotor gating deficits in neonatal ventral hippocampus-lesioned rats

Aarthi Kamath et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2008)

Article Biochemistry & Molecular Biology

Regulation of psychostimulant-induced signaling and gene expression in the striatum

Jacqueline F. McGinty et al.

JOURNAL OF NEUROCHEMISTRY (2008)

Article Pharmacology & Pharmacy

Haloperidol and clozapine differentially affect the expression of arrestins, receptor kinases, and extracellular signal-regulated kinase activation

Mohamed Rafiuddin Ahmed et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)

Article Clinical Neurology

Possible involvement of post-dopamine D2 receptor signalling components in the pathophysiology of schizophrenia

Shirly Amar et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2008)

Review Cell Biology

Expanding mTOR signaling

Qian Yang et al.

CELL RESEARCH (2007)

Article Biochemistry & Molecular Biology

Haloperidol and clozapine differentially regulate signals upstream of glycogen synthase kinase 3 in the rat frontal cortex

Myoung-Sun Roh et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2007)

Review Biochemistry & Molecular Biology

AKT/PKB signaling: Navigating downstream

Brendan D. Manning et al.

Article Clinical Neurology

Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics

Xiaohua Li et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2007)

Article Neurosciences

Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo

Jean-Martin Beaulieu et al.

JOURNAL OF NEUROSCIENCE (2007)

Review Pharmacology & Pharmacy

The Akt-GSK-3 signaling cascade in the actions of doparnine

Jean-Martin Beaulieu et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2007)

Article Biochemistry & Molecular Biology

Paradoxical striatal cellular signaling responses to psychostimulants in hyperactive mice

Jean-Martin Beaulieu et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2006)

Article Biochemistry & Molecular Biology

Failure to support a genetic contribution of AKT1 polymorphisms and altered AKT signaling in schizophrenia

Masayuki Ide et al.

JOURNAL OF NEUROCHEMISTRY (2006)

Article Clinical Neurology

Psychotropic drugs affect Ser9-phosphorylated GSK-3β protein levels in rodent frontal cortex

Nitsan Kozlovsky et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2006)

Review Pharmacology & Pharmacy

The structural basis of arrestin-mediated regulation of G-protein-coupled receptors

Vsevolod V. Gurevich et al.

PHARMACOLOGY & THERAPEUTICS (2006)

Review Biotechnology & Applied Microbiology

Arrestins: ubiquitous regulators of cellular signaling pathways

Eugenia V. Gurevich et al.

GENOME BIOLOGY (2006)

Article Biochemistry & Molecular Biology

Dopamine D1 receptor interaction with arrestin3 in neostriatal neurons

TA Macey et al.

JOURNAL OF NEUROCHEMISTRY (2005)

Article Multidisciplinary Sciences

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

DD Sarbassov et al.

SCIENCE (2005)

Article Neurosciences

Cocaine-induced changes in the expression of apoptosis-related genes in the fetal mouse cerebral wall

SI Novikova et al.

NEUROTOXICOLOGY AND TERATOLOGY (2005)

Article Multidisciplinary Sciences

Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade

JM Beaulieu et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Article Genetics & Heredity

Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia

ES Emamian et al.

NATURE GENETICS (2004)

Article Biochemistry & Molecular Biology

D1 dopamine receptor mediates dopamine-induced cytotoxicity via the ERK signal cascade

J Chen et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2004)

Review Clinical Neurology

Differential expression of mitogen-activated protein kinases and immediate early genes fos and jun in thalamus in schizophrenia

SV Kyosseva

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2004)

Article Pharmacology & Pharmacy

Preferential interaction between the dopamine D2 receptor and arrestin2 in neostriatal neurons

TA Macey et al.

MOLECULAR PHARMACOLOGY (2004)

Article Clinical Neurology

AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test

TD Gould et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2004)

Article Multidisciplinary Sciences

Diverse psychotomimetics act through a common signaling pathway

P Svenningsson et al.

SCIENCE (2003)

Review Endocrinology & Metabolism

Gender differences in schizophrenia

H Häfner

PSYCHONEUROENDOCRINOLOGY (2003)

Article Biochemistry & Molecular Biology

Differential regulation of the dopamine D2 and D3 receptors by G protein-coupled receptor kinases and β-arrestins

KM Kim et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)

Article Psychiatry

Low GSK-3 activity in frontal cortex of schizophrenic patients

N Kozlovsky et al.

SCHIZOPHRENIA RESEARCH (2001)

Review Biochemistry & Molecular Biology

Cellular signaling: Pivoting around PDK-1

A Toker et al.

Article Psychiatry

Low GSK-3β immunoreactivity in postmortem frontal cortex of schizophrenic patients

N Kozlovsky et al.

AMERICAN JOURNAL OF PSYCHIATRY (2000)